“Efficacy and Safety of up to Two Years of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s74. Accessed October 24, 2025. https://skin.dermsquared.com/skin/article/view/1831.